MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur’s agreement to develop and commercialise MEDI8897.

Gowling WLG has advised on the transaction MEDI8897 is a monoclonal antibody for the prevention of lower respiratory tract illness (LRTI) caused by respiratory syncytial virus…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Celsius Holdings’ $75 Million Acquisition of Big Beverages Contract Manufacturing

Charter Communications’ Acquisition of Liberty Broadband Corporation

Franchise Group’s Debt Financing Agreement with First Lien Lenders

CNH Industrial Capital Argentina’s US$28 Million Notes Issuance

Acqualimp’s Acquisition of Tigre

LHG Mining’s R$3.6 Billion Financing

Intera Partners’ Acquisition of Halon Security

HungryPanda’s $55 Million Funding and Refinancing Round

Holkham Estate’s Acquisition Of Six Caravan Parks And A Caravan Distribution Sales Business From McDonnell Caravans

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Gordon Technologies’ Acquisition of Vertex Downhole Trading

Polyrizon’s $4.2 Million Initial Public Offering

Nala Renewables’ Financing Of 99.2MW Onshore Wind Project In Romania

Downhole Products Limited’s Acquisition of Sledgehammer Oil Tools Private Limited

LGT Crestone’s Acquisition of Commonwealth Private Advice

Intudo’s US$125 Million Closing of Intudo Ventures IV and Natural Resources Fund

Aloke Chakravarty Joins Saul Ewing’s Boston Office

Demarest announces new Dispute Resolution partner

Venture Financing Partner N. Danny Shulman Joins Honigman in Washington

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Aloke Chakravarty Joins Saul Ewing’s Boston Office

Demarest announces new Dispute Resolution partner

Venture Financing Partner N. Danny Shulman Joins Honigman in Washington

MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur’s agreement to develop and commercialise MEDI8897.

Standard 1 Year Membership Required

Author: Paolo Bossi

Standard 1 Year Membership Required